Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.

Pauline Corbaux,Benoit You,Rosalind M Glasspool,Nozomu Yanaihara,Anna V Tinker,Kristina Lindemann, Isabelle L Ray-Coquard,Mansoor R Mirza,Fabien Subtil,Olivier Colomban,Julien Péron,Eleni Karamouza,Iain McNeish,Caroline Kelly,Tatsuo Kagimura,Stephen Welch,Liz-Anne Lewsley,Xavier Paoletti,Adrian Cook

European journal of cancer (Oxford, England : 1990)（2023）

引用 1|浏览36

暂无评分

摘要

KELIM is an independent prognostic biomarker for survival, complementary to surgery outcome, representing a new determinant of first-line treatment success.

查看译文

关键词

CA-125, KELIM, Ovarian cancer, Primary chemosensitivity, Prognostic biomarker, Surrogate end-point

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要